Comparative Effectiveness of IIMR Versus CDSMP
Launched by DARTMOUTH-HITCHCOCK MEDICAL CENTER · May 28, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to compare two programs that help people with serious mental illnesses manage their health. The study will enroll 600 individuals receiving care at Centerstone in Kentucky and Tennessee. One program, called Integrated Illness Management and Recovery (I-IMR), focuses on teaching both physical and mental health self-management skills. The other program is the Stanford Chronic Disease Self-Management Program (CDSMP), which mainly helps with managing physical health issues. By comparing these two programs, researchers hope to find out which one better supports people in improving their overall health.
To be eligible for the study, participants must have a serious mental illness, such as schizophrenia or bipolar disorder, and also have a chronic medical condition that increases their risk for serious health issues. They should have received some form of medical care, like an emergency room visit or hospitalization, within the past year. Individuals who do not speak English, have a well-controlled medical condition, or live in a nursing home will not be included. Those who join the study can expect to learn valuable skills to help manage their health better, and they will contribute to research that could improve treatment options for others facing similar challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Serious Mental Illness (diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, or chronic depression with moderate impairment in functioning) receiving services at Centerstone(KY and TN)
- • Diagnosis of a chronic medical condition increasing risk of early mortality from cardiovascular or respiratory disease (e.g., diabetes, hyperlipidemia, hypertension, COPD, heart failure, tobacco dependence, obesity), and at least 1 ER visit or hospitalization within the past year or judgment by the treatment team of substantial need for illness self-management training.
- Exclusion Criteria:
- • Consumers who do not speak English
- • Consumers with either no, or a well-controlled medical condition will not be included
- • Individuals residing in a nursing home or other institution
- • Evidence of significant cognitive impairment as indicated by a Mini Mental Status Examination score \<24, will be excluded
- • Eligibility for the COVID -related substudy is dependent on enrollment and participation in the parent project.
About Dartmouth Hitchcock Medical Center
Dartmouth-Hitchcock Medical Center (DHMC) is a leading academic medical institution located in Lebanon, New Hampshire, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a major teaching hospital affiliated with the Geisel School of Medicine at Dartmouth, DHMC integrates cutting-edge clinical trials and translational research into its comprehensive patient care approach. The center emphasizes collaboration across disciplines, aiming to enhance patient outcomes through rigorous scientific investigation, education, and community engagement. With a focus on ethical practices and patient safety, DHMC is dedicated to contributing to the advancement of medical knowledge and improving health care delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Louisville, Kentucky, United States
Patients applied
Trial Officials
Sarah Pratt
Principal Investigator
Dartmouth-Hitchcock Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials